FRIDAY, Nov. 21, 2025 (HealthDay News) — Pfizer’s mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 ...

The U.S. flu season is starting slowly, and it’s not clear if it will be as bad as last winter’s. But some health experts are ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the results of a clinical trial.

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The United States may be headed for a rough flu season, with a virus that causes more severe symptoms than the one last year ...

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

Vaccine mismatches may raise severity risks this flu season. Low vaccination uptake increases overall flu transmission ...

The vaccine has been approved by HSA for use in individuals aged 2 to 49 years. Read more at straitstimes.com. Read more at ...

Vermont added only 9 positive flu tests in Friday’s report, but those numbers will increase. Health officials are suggesting ...

Last winter, for the first time since Covid-19 entered our world, influenza reclaimed its spot as the worst actor among the cast of viruses that sicken people during the cold and flu season. The ...

A Fredericton-based pharmacist says people are still showing up to get vaccinated for influenza, despite recent news that ...